FDA Approves Marketing of Nicotine Pouches

2025-06-24 07:43:49

(MENAFN- Asdaa BCW) The U.S. Food and Drug Administration (FDA) has authorized the marketing of a few nicotine pouch products in the United States of America. This decision, based on a thorough scientific review, which were developed as an alternative for adult smokers. These pouches contain nicotine and are used by placing them between the gum and the lip, offering a less harmful alternative compared to traditional smoking.

ZYN Nicotine Pouches products have received FDA authorization after the agency confirmed that they meet the public health standards outlined in the Family Smoking Prevention and Tobacco Control Act of 2009. Studies have shown that these products present a less harmful choice than cigarettes, as they have been classified as posing less harm of serious diseases such as cancer, compared to other tobacco types.

In a comment on this statement, Dr. Matthew Farrelly, Director of the Office of Science at the FDA's Center for Tobacco Products, said:"The scientific evidence confirms that these products offer a less harmful option for adult smokers who are switching to less harmful alternatives."

In a statement, Dr. Brian King, Director of the Center for Tobacco Products at the FDA, emphasized the importance of responsible marketing for these products, saying: “It is essential that these products be marketed in a way that prevents their use by youth. While current data shows a decrease in their use among youth, the FDA is closely monitoring the market and will take appropriate action as needed to protect public health."

The authorized products come in two nicotine strengths: 3mg and 6mg. Despite this approval, the FDA emphasized that this does not mean these products are safe or 'FDA-approved'. They also affirmed that no tobacco product is entirely safe.

The FDA stated that they will closely monitor the marketing and use of these products and will take necessary actions, including suspending or revoking authorization if needed, to effectively protect public health.

MENAFN24062025002844009143ID1109715835

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.